From Clinical Thyroidology® for the Public: Papillary thyroid cancer has an excellent prognosis. Since the vast majority of patients with papillary thyroid cancer do not die of their cancer, it can be difficult to evaluate the effect of treatment on overall survival. This study was performed to evaluate whether the use of radioactive iodine therapy can improve survival in patients with low-to-intermediate risk papillary thyroid cancer that have spread of the cancer to lymph nodes in the neck at the time of surgery. Read More…
We welcome your feedback and suggestions. Let us know what you want to see in this publication.
Feedback & Suggestions
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.